These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8355457)

  • 21. Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation.
    Changsirikulchai S; Domrongkitchaiporn S; Sirikulchayanonta V; Ongphiphadhanakul B; Kunkitti N; Stitchantrakul W; Radienahamed P
    J Med Assoc Thai; 2000 Oct; 83(10):1223-32. PubMed ID: 11143489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.
    Salusky IB; Coburn JW; Brill J; Foley J; Slatopolsky E; Fine RN; Goodman WG
    Kidney Int; 1988 May; 33(5):975-82. PubMed ID: 3392886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal osteodystrophy in CAPD.
    Hutchison AJ; Freemont AJ; Lumb GA; Gokal R
    Adv Perit Dial; 1991; 7():237-9. PubMed ID: 1680434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The spectrum of bone disease in 200 chronic hemodialysis patients: a correlation between clinical, biochemical and histological findings.
    Duarte ME; Peixoto AL; Pacheco AS; Peixoto AV; Rodriguez RD; Lugon JR; Cruz EA
    Sao Paulo Med J; 1998; 116(5):1790-7. PubMed ID: 10030103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease.
    Felsenfeld AJ; Rodriguez M; Coleman M; Ross D; Llach F
    Kidney Int; 1989 Jun; 35(6):1371-8. PubMed ID: 2770115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of renal osteodystrophy in hemodialysis patients.
    DeVita MV; Rasenas LL; Bansal M; Gleim GW; Zabetakis PM; Gardenswartz MH; Michelis MF
    Medicine (Baltimore); 1992 Sep; 71(5):284-90. PubMed ID: 1522804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide.
    Hercz G; Andress DL; Nebeker HG; Shinaberger JH; Sherrard DJ; Coburn JW
    Am J Kidney Dis; 1988 Jan; 11(1):70-5. PubMed ID: 3337101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.
    Coen G; Ballanti P; Bonucci E; Calabria S; Costantini S; Ferrannini M; Giustini M; Giordano R; Nicolai G; Manni M; Sardella D; Taggi F
    Nephron; 2002 May; 91(1):103-11. PubMed ID: 12021526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.
    Gal-Moscovici A; Popovtzer MM
    Clin Nephrol; 2005 Apr; 63(4):284-9. PubMed ID: 15847255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.
    Andress DL; Maloney NA; Endres DB; Sherrard DJ
    J Bone Miner Res; 1986 Oct; 1(5):391-8. PubMed ID: 3503554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of fracturing renal osteodystrophy by desferrioxamine.
    Ackrill P; Day JP; Garstang FM; Hodge KC; Metcalfe PJ; Benzo Z; Hill K; Ralston AJ; Ball J; Denton J
    Proc Eur Dial Transplant Assoc; 1983; 19():203-7. PubMed ID: 6878234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early deposition of aluminum in bone in diabetic patients on hemodialysis.
    Andress DL; Kopp JB; Maloney NA; Coburn JW; Sherrard DJ
    N Engl J Med; 1987 Feb; 316(6):292-6. PubMed ID: 3807961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractures and vertebral bone mineral density in patients with renal osteodystrophy.
    Piraino B; Chen T; Cooperstein L; Segre G; Puschett J
    Clin Nephrol; 1988 Aug; 30(2):57-62. PubMed ID: 3180516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone aluminum accumulation in hemodialysis patients: a longitudinal perspective.
    Kopp JB; Andress DL; Maloney NA; Sherrard DJ
    Am J Kidney Dis; 1988 Sep; 12(3):214-9. PubMed ID: 3414677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal osteodystrophy and aluminum bone disease in CAPD patients.
    Gokal R
    Clin Nephrol; 1988; 30 Suppl 1():S64-7. PubMed ID: 3052962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The spectrum of bone disease in end-stage renal failure--an evolving disorder.
    Sherrard DJ; Hercz G; Pei Y; Maloney NA; Greenwood C; Manuel A; Saiphoo C; Fenton SS; Segre GV
    Kidney Int; 1993 Feb; 43(2):436-42. PubMed ID: 8441240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adynamic bone and chronic renal failure: an overview.
    Cannata Andía JB
    Am J Med Sci; 2000 Aug; 320(2):81-4. PubMed ID: 10981480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH.
    Torres A; Lorenzo V; Hernández D; Rodríguez JC; Concepción MT; Rodríguez AP; Hernández A; de Bonis E; Darias E; González-Posada JM
    Kidney Int; 1995 May; 47(5):1434-42. PubMed ID: 7637272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for a toxic effect of aluminum on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease.
    Parisien M; Charhon SA; Arlot M; Mainetti E; Chavassieux P; Chapuy MC; Meunier PJ
    J Bone Miner Res; 1988 Jun; 3(3):259-67. PubMed ID: 3213621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on the pathogenesis and pathophysiology of renal osteodystrophy. II. Bone histology of chronic renal failure patients at the time of starting hemodialysis].
    Sato T
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1145-58. PubMed ID: 7815747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.